Nephrogenic systemic fibrosis in advanced chronic kidney disease: A single hospital's experience in Taiwan

被引:8
作者
Chen, WenChieh [2 ]
Huang, Shen-Lin [2 ]
Huang, Ching-Shin [2 ]
Tsai, Min-Chien [2 ]
Lai, Han-Ming [3 ]
Lui, Chun-Chung [4 ]
Eng, Hock-Liew [5 ]
Chang, Hsueh-Wen [6 ]
Lee, Chih-Hsiung [1 ]
Chuang, Feng-Rong [1 ]
机构
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Div Nephorol, Kaohsiung, Taiwan
[2] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Dermatol, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Div Rheumatol, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Radiol, Kaohsiung, Taiwan
[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung, Taiwan
[6] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan
关键词
advanced chronic kidney disease; dialysis; gadolinium; nephrogenic systemic fibrosis; GADODIAMIDE INJECTION; DERMOPATHY; GADOLINIUM; TISSUE; CELLS; INVOLVEMENT; COLLAGEN;
D O I
10.1684/ejd.2008.0545
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD) clinically resembles scleromyxedema which develops in the setting of advanced chronic kidney diseases. Limited data exist about its epidemiology in Asian countries. A total of 153 magnetic resonance imaging (MRI) examinations, including 81 contrast-enhancement, were identified in 127 patients with advanced chronic kidney disease at stage five undergoing MRI or angiography examination between January 2005 and July 2007, in our hospital. The diagnosis of NFD/NSF was established based on clinical manifestation and histopathology. NFD/NSF was diagnosed in none of the 105 patients on haemodialysis but in one of the 22 patients on peritoneal dialysis. This 24-year-old woman was a case of systemic lupus erythematosus since age 15 and who developed skin lesions two months before the initiation of peritoneal dialysis but nine months after four exposures to gadodiamide during MRI study. The skin condition had significantly improved within three months under a combination regimen of systemic pentoxifylline and topical clobetasol propionate ointment, with further amelioration during subsequent treatment with colchicine. Our results lend support to the predisposition of gadolinium-containing contrast agents to the development of NFD/NSF in patients with advanced renal failure, even before the initiation of dialysis. The cause of a lower incidence rate in our series remains to be determined.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 52 条
[1]
Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis [J].
Baron, PW ;
Cantos, K ;
Hillebrand, DJ ;
Hu, KQ ;
Ojogho, ON ;
Nehlsen-Cannarella, S ;
Concepcion, W .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2003, 25 (03) :204-209
[2]
PENTOXIFYLLINE INHIBITS THE PROLIFERATION OF HUMAN FIBROBLASTS DERIVED FROM KELOID, SCLERODERMA AND MORPHEA SKIN AND THEIR PRODUCTION OF COLLAGEN, GLYCOSAMINOGLYCANS AND FIBRONECTIN [J].
BERMAN, B ;
DUNCAN, MR .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 123 (03) :339-346
[3]
Gadolinium deposition in nephrogenic fibrosing dermopathy [J].
Boyd, Alan S. ;
Zic, John A. ;
Abraham, Jerrold L. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :27-30
[4]
Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned [J].
Broome, Dale R. ;
Girguis, Mark S. ;
Baron, Pedro W. ;
Cottrell, Alfred C. ;
Kjellin, Ingrid ;
Kirk, Gerald A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (02) :586-592
[5]
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P25
[6]
Cheng S., 2007, Morbidity and Mortality Weekly Report, V56, P137
[7]
Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin [J].
Chung, HJ ;
Chung, KY .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (03) :596-597
[8]
Nephrogenic systemic fibrosis: The nosological and conceptual evolution of nephrogenic fibrosing dermopathy [J].
Cowper, SE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) :763-765
[9]
Scleromyxoedema-like cutaneous diseases in renal-dialysis patients [J].
Cowper, SE ;
Robin, HS ;
Steinberg, SM ;
Su, LD ;
Gupta, S ;
LeBoit, PE .
LANCET, 2000, 356 (9234) :1000-1001
[10]
Nephrogenic fibrosing dermopathy: the first 6 years [J].
Cowper, SE .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (06) :785-790